Feature Article

Solid organ transplantation and endocrine sequelae. What to be aware of

Feature Article

Solid organ transplantation and endocrine sequelae. What to be aware of

Lisa M. Raven, Jerry R. Greenfield

Figures

© aliaksandr marko/ stock.adobe.com
© aliaksandr marko/ stock.adobe.com

Abstract

Recipients of solid organ transplant are managed by a specialist team. However, as the number of transplantations increases and survival improves, the care of these patients will be shared with GPs and other physicians. Endocrine pathology is common after transplantation and requires lifelong monitoring and management.

Key Points

  • Endocrine complications such as diabetes and osteoporosis are common after solid organ transplantation.
  • Management of post-transplant diabetes needs to be individualised, but standard monitoring for diabetic complications should be continued.
  • If the corticosteroid dose increases, glucose levels should be closely monitored and treatment titrated.
  • Osteoporosis is common before and after transplantation, and nonpharmacological management should be optimised, with individualised therapeutic treatment.
  • If a fracture occurs in a patient, osteoporosis management should be reassessed.